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a b s t r a c t
Ethnopharmacological relevance: Traditional Chinese medicine (TCM) formula of Yaotongning Capsules
(YTNC) is a common remedy to treat rheumatism (RA) in China and possesses diverse biological activities
including anti-inﬂammation. However the effects of component material medicines (CMMs) in YTNC and
different combinations of the CMMs on the efﬁcacy of YTNC and the interactions of these CMMs have been
being unclear due to ten CMMs and too many compounds involved in YTNC. Moreover, many TCM formulae
are available for treating RA according to TCM theory. It is unknown if the YTNC prescription is better than
other TCM formulae for treating RA or better efﬁcacy could be obtained when some CMMs in YTNC are
replaced by other herbs. Quantitatively investigate the in vitro effect of active fractions from the CMMs of YTNC
and other eight herbs commonly used in the TCM formulae for RA treatment on anti-inﬂammatory activity of
different combinations of the active fractions, the interactions of the active fractions to evaluate the
reasonability, advantage (or disadvantage) of the YTNC prescription and to see if the prescription could be
improved from the point of anti-inﬂammation.
Materials and Methods: Twenty-six active fractions, which were categorized as alkaloids, ﬂavonoids, saponins,
volatile oils/aqueous extracts and polysaccharides were prepared to design TCM samples by combining some of
the active fractions, based on the YTNC formulating principle, combination chemistry concept and the
importance of the active fractions in YTNC. The anti-inﬂammatory activities of the samples were evaluated by
their half-maximal inhibitory concentration (IC50) values that inhibiting the production of prostaglandin E2
(PGE2) in ANA-1 murine macrophages (ANA-1 cells). The cells plated in 96-well plates were classiﬁed into
blank group and test sample group. Each groupwas stimulated with lipopolysaccharides (LPS, 1 mg/mL) for 2 h.
ANA-1 cells were pretreated with different concentrations of test samples prior to the addition of arachidonic
acid (10 μmol/L). The supernatants were collected andmeasured using PGE2 ELISA Kit, and the cytotoxicity was
assayed by cell counting Kit-8 (CCK8)-based test. The interactions of the active fractions in YTNC were
evaluated by comparing the experimental IC50 values of the samples derived from YTNC to their corresponding
additive IC50 values. The effect of each active fraction on cellular anti-inﬂammation–PGE2 secretion inhibition
activity, and the reasonability, advantages (or disadvantages) of YTNC were evaluated based on the comparison
of IC50 values of the samples.
Results: The disassembled formulae consisted of some active fractions of YTNC and the whole prescription of
YTNC consisted of the all active fractions from YTNC all demonstrate cellular anti-inﬂammatory activity, and
there were no signiﬁcant differences between these formulae. The vehicle of YTNC Chinese rice wine exhibits
the ability to enhance the cellular anti-inﬂammation of YTNC. Synergistic effect exerts in the combination of
alkaloids, ﬂavonoids and saponins of YTNC, antagonistic or additive effects occur in the other combinations of
active fractions from YTNC. The anti-inﬂammatory activities of some TCM samples which include some active
fractions from the eight selected herbs are signiﬁcantly higher than the samples derived from YTNC. The
ﬂavonoids of Carthamus tinctorius, the volatile oils of Cinnamomum cassia and Angelica pubescens perform
better in cellular anti-inﬂammation than the ﬂavonoids and volatile oils in YTNC.
Conclusions: The prescription of YTNC is reasonable in the view of anti-inﬂammation. The saponins and
polysaccharides from the CMMs of YTNC have better anti-inﬂammatory activities than the saponins and
polysaccharides from the other eight herbs. Reducing the varieties of YTNC CMMs and replacing the ﬂavonoids
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and volatile oils of YTNC with the ﬂavonoids of Carthamus tinctorius and the volatile oils of Cinnamomum cassia
(or Angelica pubescens) would improve the safety and anti-inﬂammatory activity of YTNC. Synthetically
evaluating various pharmacological activities of TCM formulae designed in the present work may lead to
develop more effective and safer TCM using YTNC as prototypes.
& 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Rheumatism (RA) affects human body's bones, joints and soft
tissue, and often comes with arthrodynia and limitation in func-
tion, which normally leads to changes in gait patterns owing to
pain (Kaufman et al., 2001). These symptoms concern with the
inﬂammation occurring on relative bone joints and bring a lot of
pain and inconvenience to patients. Modern medicine usually
treats the disease by suppressing pain, diminishing inﬂammation
and improving human body's immunity etc. (Belch et al., 1988;
Simon et al., 1999; Bauerová et al., 2011). There are many options
for treating RA in terms of Traditional Chinese Medicine (TCM)
theory because different TCM formulae are prescribed for same
disease due to individual differences of pathogenesis and progres-
sion of patients. In clinical, this practice is referred as treating
same disease with different methods (Wang et al., 2009a). After
sorting and categorizing the TCM prescriptions for treating RA
during recent 10 years, our research team found that there were
154 TCM formulae including Yaotongning Capsules (YTNC) (Fang,
2013), which exhibits a clear anti-inﬂammatory and analgesic
effect, and the capability of strengthening immune activity and
activating blood circulation (Pharmacopeia Committee of
PR China, 2010), and has been used clinically to treat RA for
decades in China.
According to TCM formulating theory, a TCM formula is usually
consisted of one or two principal component material medicines
(CMMs, i.e., the fundamental elements of TCM formulae) and other
CMMs that assist the effects of the principal one as adjuvant parts
(Anonymous, 1999). It is believed that reasonable combination of
CMMs can exert synergic effects and toxicity reduction. Strychnos
nux-vomica L., seed (Ma Qian Zi) is the principal medicine of YTNC.
It has analgesic and anti- inﬂammatory etc. functions (Chen et al.,
2012). The other nine material medicines Ephedra sinica Stapf,
stalk (Ma Huang), Glycyrrhiza uralensis Fisch., root (Gan Cao),
Atractylodes lancea (Thunb.) DC., root and rhizome (Cang Zhu),
Boswellia sacra Flueck., resin (Ru Xiang), Commiphora myrrha
(Nees) Engl., resin (Mo Yao), Cyathula ofﬁcinalis K. C. Kuan, root
(Chuan Niu Xi), Eupolyphaga sinensis, whole insect (Tu Bie Chong),
Buthus martensii Karsch, whole insect (Quan Xie), Bombyx mori L.
infected by Beauveria bassiana (Bals.) Vuill, whole insect (Jiang
Can) are crushed into powder and mixed with the powder of
Strychnos nux-vomica to intensify its action and provide extra
functions such as protentiation of immunological response or
invigoration of blood circulation. As the vehicle of YTNC, Chinese
rice wine is taken with YTNC by the patients to improve the drug
absorption. However the effects of the CMMs on the efﬁcacy of
YTNC and the interactions of these CMMs have been being unclear
due to ten CMMs and too many compounds included in YTNC.
Moreover, it is unknown if the YTNC prescription is better than
other TCM formulae for treating RA or better efﬁcacy could be
obtained when some CMMs in YTNC are replaced by other herbs.
Recently, the synergistic/antagonistic effects of some TCM sam-
ples consisted of two to three of crude extracts or several main
components have been elucidated successfully by molecular phar-
macology (Wang et al., 2008; Ma et al., 2009; Lau et al., 2012; Wang
et al., 2012a). The studies provide a potential way to rapidly
investigate the effect of different combinations of active compounds
(or extracts) on the pharmacological activities of TCM and the
interactions of selected compounds. However the TCM samples in
the published literatures were designed by combining some main
inclusions (or crude extracts) in the formulae in equal ratio or the
ratios determined by orthogonal experimental tables without con-
sidering the formulating principle of the investigated TCM. The
samples designed by this way are not able to properly represent the
actual compositions and functions of different CMMs in the TCM
formulae. Active fractions, which are puriﬁed from CMMs and have
similar molecular skeletons such as alkaloids, ﬂavonoids, saponins
and polysaccharides, will be good fundamental elements for con-
structing TCM samples because the interfering factors inhibiting the
activity of TCM and the in-active substances such as starch and
tannins can be removed by this way (Zhang et al., 2007a). Moreover,
the reported studies evaluated the pharmacological activities of TCM
samples by comparing their signiﬁcant differences between the
samples' test values, rather than by quantitative evaluation indices
such as half-maximal inhibition concentration (IC50) values. Some-
times the actual activity of TCM samples may be covered by the
comparisons of the signiﬁcant differences. And more importantly,
just investigating a TCM alone cannot demonstrate whether the
TCM is better than other TCMs for treating the same disease or if the
TCM's formula could be improved.
Basing on above considerations, besides the ten CMMs and the
vehicle of YTNC - Chinese rice wine, other extra 8 herbs (Panax
notoginseng (Burkill) F. H. Chen, stalk (San Qi), Taxillus chinensis
(DC.) Danser, stalk and twig (Sang Ji Sheng), Angelica pubescens
Maxim., root (Du Huo), Carthamus tinctorius L., ﬂower (Hong Hua),
Davallia mariesii T. Moore ex Baker, root and rhizome (Gu Sui Bu),
Panax ginseng C.A.Mey., root (Ren shen), Epimedium sagittatum
(Siebold & Zucc.) Maxim., whole plant (Yin Yang Huo), Cinnamo-
mum cassia (Nees & T.Nees) J. Presl, twig (Gui Zhi), which are
frequently applied in the other 153 TCM formulae for treating RA
and have similar functions to those in YTNC, were also selected as
CMMs of this study. To represent the actual active material
foundation of TCM as far as possible and avoid false positive/
negative results that might be caused by directly using herb
powders or crude extracts in cellular experiments due to their
poor solubility, we puriﬁed 26 active fractions from the 19 CMMs
in the categories of alkaloids, ﬂavonoids, saponins, volatile oils/
aqueous extracts and polysaccharides. As reported in the litera-
tures, the 26 active fractions have the pharmacological activities
including analgesic, anti-inﬂammatory and immune activity, acti-
vating blood circulation and metabolism etc. functions (see
Table 1) that are similar to YTNC's. Therefore they may be effective
parts of TCM formulae for treating RA and be suitable for the
elements used to design TCM samples. According to the formulat-
ing principle of YTNC and the importance of the active fractions in
the prescription of YTNC, and by means of the concept of
combination chemistry, different TCM samples were designed by
combing some of the 26 active fractions in proper way.
Modern pharmacological study shows that the production of
RA is related to the responses of organism defense, especially the
inﬂammatory cytokines in cells such as prostaglandin E2 (PGE2).
The higher the concentration of PGE2 in cells is, the more severe
inﬂammation is (Sung et al., 2012; Yoon et al., 2013). Therefore
comparing the half-maximal inhibitory concentration (IC50) values
of the TCM samples that inhibit the production of prostaglandin E2
(PGE2) in cells will help us to investigate the effect of the active
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fractions on anti-inﬂammatory activity and interactions of the active
fractions. Finally the reasonability, advantage (or disadvantage) of
YTNC's prescription and if the prescription could be improved from
the point of anti-inﬂammation would be understood. Furthermore,
the combinations of active fractions with better cellular anti-
inﬂammatory activity would be discovered from a series of samples
using YTNC as prototypes.
2. Materials and methods
The research rationale of the present study is illustrated in
Fig. 1. The samples in the dotted box are the whole recipe of YTNC
(AyFySyVyPyþextract of Chinese rice wine) and the disassembled
formulae of YTNC consisting of Ay, AyFy, AyFySy, AyFySyVy and
AyFySyVyPy, respectively. The proportions of the active fractions in
these 6 samples are arranged according to the actual mass ratios of
corresponding CMMs in YTNC. By comparing the IC50 value of each
sample with its subsequent sample's, the effects of alkaloids,
ﬂavonoids, saponins, volatile oils/aqueous extracts and polysac-
charides in YTNC on cellular anti-inﬂammatory activity were
assessed. Moreover, we developed a method for estimating the
additive IC50 value of a TCM sample based on least square
optimality principle (Section 2.5). By means of comparing the
experimental IC50 value with the additive IC50 value of each YTNC
sample, the synergetic, antagonistic or additive actions among the
active fractions in the sample were investigated.
As for the samples out of the dotted box, the mass ratio of the
active fractions in them are arranged as followings: A:Fi¼1:1 (Fi
represents one of the ﬂavonoids from the 18 CMMs); A:F:Si¼0.5:0.5:1
Table 1
Information list of the 10 CMMs of YTNC and the eight selected herbs and their active fractions (AC for short).
CMM (batch number
and frequency used
in formulae for
treating RA)
AC Content in
the CMM (mg/g)
The type of AC AC content
in the extract
Method of extraction Pharmacological activity
Strychnos nux-vomicaa (Lot.
Y302-09091-10, 15 times)
40 Alkaloids 0.89 g/g Heating reﬂux method
(HRE)
Analgesic and anti-inﬂammatory activity Yin et al.
(2003), Chen et al. (2012)
Ephedra sinicaa (Lot.Y412-
100601-12, 28 times)
15 Alkaloids 0.50 g/g HRE Effect on central nervous system Ma et al. (2007)
50 Polysaccharides 0.35 g/g Water extraction and
alcohol precipitation (WE
and AP) Ni et al. (2014)
Immune activity Kuang et al. (2011)
Glycyrrhiza uralensisa (Lot.
Y013-110301-1, 30 times)
40 Flavonoids 0.45 g/g HRE and Macroporous
resin absorption (HRE &
MRA)
Antibacterial and antiviral actions Haraguchi et al.
(1998), Fuhrman et al.(2002)
80 Saponins 0.78 g/g HRE & MRA Fang (2013) Anti-inﬂammatory action (Akamatsu et al. (1991)
100 Polysaccharides 0.33 g/g WE and AP Ni et al. (2014) Immune activity Cheng et al. (2008)
Cyathula ofﬁcinalisa (Lot.Y012-
110401-1, 35 times)
15 Saponins 0.16 g/g HRE & MRA Fang (2013) Analgesic activity Gao, et al. (2003),
immunogenicity Zhou et al. (2005)
75.7 Polysaccharides 0.96 g/g WE and AP Ni et al. (2014) Adjusting immunogenicity Feng et al. (In press)
Atractylodes lanceaa (Lot.Y002-
101001-2, 18 times)
51 Volatile oils 1 mL/mL Water extraction coupling
rectiﬁcation (WER) Zhang
et al. (2011)
Antimicrobial activity Wang et al. (2009b)
28.5 Polysaccharides 0.63 g/g WE and AP Ni et al. (2014) Immune activity Yu et al. (1998)
Boswellia sacraa (Lot.110301-2,
25 times)
55 Volatile oils 1 mL/mL WER Zhang et al. (2011) Anti-inﬂammation and anti-bacterium action
Singh and Atal (1986), Jing et al. (1999)
Commiphora myrrhaa
(Lot.110401-1, 24 times)
57.5 Volatile oils 1 mL/mL WER Zhang et al. (2011) Anti-inﬂammation and anti-bacterium activity
Fourie and Snyckers (1989)
Eupolyphaga sinensisa (Lot.
Y803-110101-5, 5 times)
— Aqueous
extracts
0.10 g/mL Ultrasound extraction
(UE)
Anti-thrombosis activity Wang et al. (2012b)
Buthus martensiia (Lot.Y804-
11302-4, 5 times)
— Aqueous
extracts
0.10 g/mL UE Nervous system activation, antivenin
administration and cardiovascular manifestations
Davila et al. (2002)
Bombyx moria (Lot.Y805-
1011054, 6 times)
— Aqueous
extracts
0.10 g/mL UE Anti-thrombosis and anti-bacterium activity
(Zhang, 2012)
Panax notoginseng (Lot.Y806-
11508-7,10 times)
Saponins 0.85 g/g HRE & MRA Fang (2013) Blood lipid proﬁle and an anti-inﬂammatory action
Zhang et al. (2008)
Taxillus chinensisc (Lot.Y807-
11609-9,7 times)
Flavonoids 0.01 g/g HRE & MRA Zhang (2013) Anti-tumor activity Xiao et al. (2009)
Polysaccharides 0.38 g/g WE and AP (Ni et al. 2014) Immune activity
Angelica pubescens (Lot.Y808-
10909-4,40 times)
Volatile oils 1 mL/mL WER Zhang et al. (2011) Analgesic and anti-inﬂammatory activity Fan et al.
(2009)
Carthamus tinctorius (Lot.
Y809-10401-6,27 times)
Flavonoids 0.41 g/g HRE & MRA Zhang (2013) Activating blood circulation and anti-inﬂammation
Jin et al. (2004)
Davallia mariesii (Lot.Y810-
11907-1,13 times)
Flavonoids 0.42 g/g HRE & MRA Zhang (2013) Effect on ﬁghting RA Wang and Xu (2001)
Panax ginseng (Lot.Y811-
11706-2,24 times)
Saponins 0.89 g/g HRE & MRA (Fang, 2013) Antineoplastic and Immunomodulatory Effects
Yoon et al., (1998), Wakabayashi et al. (1998)
Epimedium sagittatum (Lot.
Y812-110808-3,8 times)
Flavonoids 0.20 g/g UE Preventing bone loss Chen et al., (2005a), Huang
et al. (2006), Zhang et al. (2007b)
Polysaccharides 0.24 g/g WE and AP Ni et al. (2014) Adjusting immunogenicity Xu and Li (2009)
Cinnamomum cassia (Lot.Y813-
110301-3,32 times)
Volatile oils 1 mL/mL WER Zhang et al. (2011) Anti-inﬂammation effect Xu et al. (2007)
Chinese Rice Wine Polysaccharides — Rotary evaporation the YTNC vehicle
Frequency indicates the times of each herb used in the 154 formulae for treating RA.
a Means the CMMs of YTNC. Accordingly, other eight herbs applied commonly were selected and listed in Table 1.
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(Si represents one of the saponins from the 18 CMMs); A:F:S:
Vi¼0.33:0.33:0.33:1 (Vi represents one of the volatile oils/aqueous
extracts from the 18 CMMs); A:F:S:V:Pi¼0.25:0.25: 0.25:0.25:1 (Pi
represents one of the polysaccharides from the 18 CMMs). By means
of this way, we designed four kinds of TCM samples of AFi, AFSi, AFSVi
and AFSVPi. Among the same kind of samples, the active fractions with
the subscript are those having similar molecular skeleton. They occupy
50% in each sample and change with CMM. By comparing the IC50
values of the same kind of samples, we quantitatively evaluate the
effect of these active fractions with the subscript on PGE2 production
inhibition. The comparison would ﬁx the active fraction that is
superior to other active fractions of the same molecular skeleton.
Fig. 1. Illustration of the investigation scheme of the present study.
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And furthermore, whether ﬂavonoids, saponins, volatile oils/aqueous
extract and polysaccharides from the CMMs of YTNC are superior to
the active fractions from the eight selected herbs or not would be
discovered.
2.1. Instruments and reagents
Analytical Balance (Shanghai Yueping Scientiﬁc Instrument Co.,
Ltd., China, YP2002), CO2 incubator (NUAIRE, America, NU-4850E),
Super Clean Bench (Air Tech, Japan, SW-CJ-1D), Computer Control
Disinfection Cabinet (OMY, Japan, SS-325), Multifunctional
Enzyme Mark Instrument (Bio-Rad, America, 680), Lipopolysac-
charides (LPS, Sigma Chemical Co., USA, Lot.111M4035V), arachi-
donic acid (Sigma Chemical Co., USA, Lot. 071M1333V), The ELISA
kits for determination of PGE2 (R&D system, USA, Lot. 303260),
Cell counting Kit-8 (CCK-8, Dojindo, Japan, Lot.DQ863). Dulbecco's
modiﬁed Eagle's medium (DMEM, Beijing Skywing Technology Co.,
Ltd., China, Lot. 120301), Newborn Calf Serum (Hangzhou Sijiqing
biological engineering materials Co., Ltd., China, Lot. 110817).
A mouse ANA-1 cell line was purchased from the Institute of
Biochemistry and Cell Biology (Shanghai, China). All the other bio-
chemicals used were of the highest grade available.
2.2. Samples preparation
Ten CMMs of YTNC, Chinese rice wine (Lot.291110) and the
eight selected herbs commonly used in the TCM formulae for RA
treatment were kindly provided by Jingfukang Pharmaceutical
Group Co., Ltd (Chengde, Hebei province, China) and identiﬁed
by licensed pharmacist Chunmin Wang. A voucher specimen has
been deposited in School of East China University of Science and
Technology, Shanghai, China. The 26 active fractions were pre-
pared in our lab and were under careful quality analysis. The detail
preparation and quality analysis of these active fractions were
introduced in the Appendix I and II of the supplementary material.
The preparation and quality analysis of some active fractions were
reported in our previous works (Ni et al., 2012, 2014; Zhang et al.,
2013a, 2013b; Zhang, 2013; Fang, 2013). The reports on the
pharmacological activities of the 26 active fractions were listed
in the column 6 of Table 1. The names of the 19 CMMs studied in
the present work, the active fractions of each CMM, the content of
the active fraction in the CMM, the quality and extraction methods
of the active fractions were listed from column 1 to column 5 of
Table 1.
The detailed combinations of the active fractions were illu-
strated in Table 2. It should be pointed that there were originally
38 samples in the list, but only 27 samples of them were
investigated in the present study. Therefore, the sample number
in Table 2 was discontinuous. Among them, samples #33-#37 and
#38 are the disassembled formulae of YTNC and the YTNC whole
recipe, respectively. The dosage of each active fraction in these six
samples was calculated as following:
The dosage of active fraction in the sample
¼ the dosage of the corresponding CMM in YTNC
 the content of the active fraction in the CMM=the content
of the active fraction in the extract ð1Þ
The dosages of the solid active fractions (alkaloids, ﬂavonoids,
saponins and polysaccharides) in YTNC were determined in
accordance with the calculation of Eq. (1). Volatile oils/aqueous
extracts (V for short) were used to prepare TCM samples as
a whole, so the denominator for calculating the dosages of V in
Eq. (1) was 1. The animal CMMs of Eupolyphaga sinensis, Buthus
martensii and Bombyx mori were extracted by using 10-fold water,
so the dosages of the three aqueous extracts were calculated by
multiplying the dosage of the three animal CMMs in YTNC by 0.10.
According to Table 2, each active fraction in the TCM samples
was weighed accurately and the active fractions, which are stable
at high temperature such as the ﬂavonoids and saponins, dissolved
in DMEM ﬁrstly. After cooling and completing dissolving, the left
fractions that are unstable at high temperature such as volatile oils
were added to the above liquid to generate mother liquor
(2500.0 μg/mL). The mother liquor were ﬁltered with 0.22 μm
membrane ﬁlters and diluted to different concentrations (3.1, 6.2,
12.5, 25.0, 50.0, 100.0, 200.0, 400.0 μg/mL) for further use.
2.3. Cell cultures, PGE2 and viability assay (Chen et al., 2005b)
The ANA-1 cells were cultured in DMEM containing 10% new-
born calf serum, 1105 U/L penicillin and 100 mg/L gentamycin in
humidiﬁed atmosphere of 5% CO2 at 37 1C. The cultured ANA-1
cells (n¼3 donors) were plated in each well of 96-well plates with
a density of 4000 cells/well and were classiﬁed into blank group
and test sample group. After 2 h incubation, the cells of blank
group and test sample group were stimulated with LPS (1 mg/mL).
After additional 9 h incubation, the cells were treated with
different concentrations (3.1, 6.2, 12.5, 25.0, 50.0, 100.0, 200.0,
400.0 μg/mL) of the test samples and were cultured for 48 h.
Incubation was stopped by the addition of arachidonic acid
(10 μmol/L). After 20 min, the supernatants were collected and
measured using PGE2 ELISA Kit as described by the manufacturer.
Brieﬂy, 50 μL supernatants were then pipetted into micro-plates
that were pre-coated with 100 μL calibrator diluent RD5-56
(attached in the kit). And 50 mL of primary antibody solutions
(attached in the kit) were added and incubated at room tempera-
ture for 1 h. Then 50 mL of PGE2 conjugates were added to each
well. After 2 h incubation at room temperature, the plates were
washed four times to remove all unbound reagents. 200 mL
substrate solutions (attached in the kit) were then added and
incubated at room temperature for 30 min on a super clean bench,
which should be protected from light. 100 mL stop solution was
ultimately added to stop the color reaction. The absorbance was
measured at 450 nm by a BioRad-680 micro plate reader.
To detect cell death-induced reduction of PGE2 production, the
ANA-1 cell viability assay was assessed using a CCK8 test in
accordance with the manufacturer's instructions. In brief, the cells
were incubated in 10 mL of CCK-8 solution for 2 h. The absorbance
of the samples was detected at 450 nm using a model BioRad-680
micro plate reader. The dose range of the samples used in the
cellular experiments was explored by referencing the dose of
YTNC to guarantee most samples not cause cell death in the range.
2.4. Statistical analysis
All experiments were repeated at least 3 times and all results
were presented as half inhibitory concentration with standard
deviation (IC507SD). We determined the inhibition ratios of the 27
samples at different concentrations based on the absorbance mea-
sured by the procedure illustrated in Section 2.3. Then we obtained
the experimental IC50 values and their standard deviance (SD) by
simulating the concentration-inhibition ratio curves with Origin 7.5.
Statistics were analyzed using one-way analysis of variance (ANOVA)
with post hoc Tukey tests using SPSS 18.0 (95% conﬁdence interval).
P-valueso0.01 were considered to be statistically signiﬁcant.
2.5. Evaluation of the effect of samples on PGE2 production inhibition
and interactions of the active fractions in YTNC
We proposed an innovative method to test whether the active
fractions of a TCM sample produce a synergic, antagonistic or
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additive effect on the investigated activity by calculating the
additive IC50 value of the TCM sample and comparing it to the
experimental IC50 value. Deﬁne the mass ratio of the ith- active
fraction in the jth-TCM sample as Xij and record the IC50 value of
this active fraction as ICi50 ði¼ 1;2;…;nÞ. Record the experimental
IC50 of the jth-TCM sample and its standard derivation as IC50 (Ej)
and SD (j), respectively (j¼1, 2,…, m). Where n, m represents the
number of active fractions and number of samples, respectively. In
the present study, n¼26 and m¼27. The additive IC50 value of the
jth-sample stands for the sum of the contributions each active
fraction in the sample to the IC50 value without considering the
interactions of the active fractions. We name it as IC50 (Aj). In terms
of the deﬁnition of additive IC50 value, it equals to the sum of the
product of Xij and IC
i
50,i.e.,
IC50ðAjÞ ¼∑iXijICi50 ð2Þ
If the active fractions in the jth-TCM sample do not produce
a synergistic or antagonistic effect, then its experimental IC50 value
should be equal to its additive IC50 value. Considering the impact
of experimental error on IC50(Ej), there is
IC50ðEjÞSDðjÞo IC50ðAjÞo IC50ðEjÞþSDðjÞ ð3Þ
It implies that additive effect occurs among the active fractions
of the jth-TCM sample.
When the active fractions in the jth-TCM sample produce
synergistic effect on the activity, its actual IC50 value (i.e., the
experimental IC50 value) is certainly lower than its additive IC50
value. Taking into account of inﬂuence of the experimental error
on IC50(Ej), there is
IC50ðEjÞþSDðjÞo IC50ðAjÞ ð4Þ
If antagonistic effect occurs among the active fractions of the
jth-TCM sample, the sample's experimental IC50 value will be
higher than its additive IC50 value. Taking into account of the
experimental error, there is
IC50ðEjÞSDðjÞ4 IC50ðAjÞ ð5Þ
According to the relationship between IC50(Ej) and IC50(Aj) as
shown by Eqs. (3)–(5), we can determine interaction types of
active fractions of a TCM sample. The additive IC50 value can be
calculated by Eq. (2). Since we did not do experiments using single
active fraction, Each ICi50 is unknown. However, we can calculate
every ICi50 by solving the equation of ∑j½∑iXijICi50 IC50ðAjÞ2 ¼ 0
under the constraints of C min o ICi50oC max. Cmin and Cmax are
the lowest and highest concentrations of TCM samples in cellular
experiments, respectively. In the present work, Cmin and Cmax
equal 3.1 μg/ML and 400.0 μg/ML, respectively (Section 3.1). Con-
straint least square optimization method was applied to obtain
Table 2
TCM samples based on different combinations of the active fractions in Table 1.
Sample number and codes
3 AFgu 4 AFes 5 AFct 6 AFdm 7 AFtc
10 AFSgu 11 AFSpn 12 AFSpg 13 AFSco
17 AFSVbc 18 AFSVal 19 AFSVap 20 AFSVcc 21 AFSVes 22 AFSVbb
27 AFSVPco 28 AFSVPgu 29 AFSVPal 30 AFSVPe 31AFSVPes 32 AFSVPtc
33 Ay
34 AyFy
35 AyFySy
36 AyFySyVy
37 AyFySyVyPy
38 AyFySyVyPyþCrw
Alkaloids: A: the mixture of Ae and As in equal ratio (for samples #3-#32) and Ay: the mixture of As and Ae in the ratio of Strychnos nux-vomica and Ephedra sinica in YTNC
(for samples #33-#38);
Ae: the alkaloids of Ephedra sinica,
As: the alkaloids of Strychnos nux-vomica,
Flavonoids (F): the mixture of Fgu, Fes,Fct, Fdm and Ftc in equal ratio (for samples #3-#32);
Fy: the falvonoids of YTNC, i.e., Fgu
Fgu: the ﬂavonoids of Glycyrrhiza uralensis,
Fes: the ﬂavonoids of Epimedium sagittatum,
Fct: the ﬂavonoids of Carthamus tinctorius,
Fdm: the ﬂavonoids of Davallia mariesii,
Ftc: the ﬂavonoids of Taxillus chinensis,
Saponins (S): the mixture of Sgu, Spn, Spg and Sco in equal ratio (for samples #3-#32) and Sy: the mixture of Sgu and Sco in the ratio of Glycyrrhiza uralensis and Cyathula
ofﬁcinalis in YTNC (for samples #33-#38);
Sgu: the saponins of Glycyrrhiza uralensis,
Spn: the saponins of Panax notoginseng,
Spg: the saponins of Panax ginseng,
Sco: the saponins of Cyathula ofﬁcinalis,
Volatile oils/aqueous extracts (V): the mixture of Vbc, Val, Vap, Vcc, Ves and Vbb in equal ratio (for samples #3-#32) and Vy: the mixture of Vbc, Val, Ves and Vbb in the ratio
of Boswellia sacra, Commiphora myrrha, Atractylodes lancea, Eupolyphaga sinensis, and Buthus martensii, Bombyx mori. in YTNC (for samples #33-#38);
Vbc: the volatile oils of Boswellia sacra and Commiphora myrrha,
Val: the volatile oils of Atractylodes lancea,
Vap: the volatile oils of Angelica pubescens,
Vcc: the volatile oils of Cinnamomum cassia,
Ves: the aqueous extracts of Eupolyphaga sinensis,
Vbb: the aqueous extracts of Buthus martensii, Bombyx mori.,
Polysaccharides (P): the mixture of Pco, Pgu, Pal, Pe, Pes and Ptc in equal ratio (for samples #3-#32) and Py: the mixture of Pgu, Pco, Pal and Pe in the ratio of Glycyrrhiza
uralensis, Cyathula ofﬁcinalis., Angelica pubescens and Ephedra sinica in YTNC (for samples #33-#38);
Pco: the polysaccharides of Cyathula ofﬁcinalis,
Pgu: the polysaccharides of Glycyrrhiza uralensis,
Pal: the polysaccharides of Atractylodes lancea,
Pe: the polysaccharides of Ephedra sinica,
Pes: the polysaccharides of Epimedium sagittatum,
Ptc: the polysaccharides of Taxillus chinensis.
Crw: the Chinense rice wine extraction.
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ICi50 that make ∑j½∑iXijICi50 IC50ðAjÞ2 minimum. The calculation
of IC50 value of every active fraction and the additive IC50 value of
every TCM sample in the present study were operated on MATLAB
(Mathworks, Ver. 7.0). The detailed MATLAB codes and explanation
were listed in the Appendix III of the supplementary material.
By comparing the IC50 values of the TCM samples in the same
row of Table 2, we can evaluate the effect of each active fraction on
PGE2 production inhibition and ﬁnd which active fraction has the
best anti-inﬂammatory activity among the same type of active
fractions. For samples #33–#38 derived from YTNC, the compar-
ison between the experimental and additive IC50 values will reveal
the interaction types of the active fractions. Furthermore, the
comparison between the IC50 values of the ﬁrst 21 samples and
sample #38 will provide evidence of the reasonability and advan-
tages (or disadvantages) of the YTNC formula.
3. Results and discussion
3.1. The effect of the TCM samples on cell viability
Table 3 showed the absorbance result of cell viability test. Most
samples that included the whole recipe of YTNC (#38) did not
result in cytotoxicity, but the cytotoxicity of some samples (with
bold ﬁgure in Table 3) was observed at the highest concentration
(400.0 μg/mL) (#7, #10, #27, #30 and #32) and the concentration
of 400-200.0 μg/mL #29) and 400-100.0 μg/mL (#20). Therefore
we deleted these concentrations when we calculated IC50 values
of these samples to ensure that the samples used in the present
study did not cause cell death at their half inhibition
concentration.
3.2. Effect of the TCM samples derived from YTNC on PGE2
production in ANA-1 cells
According to Fig. 2, for samples #33 and #36, the experimental
IC50 value –SD4the additive IC50 value. It implies that the active
fractions in these two samples exert antagonistic effects on
inhibiting PGE2 production; For samples #34, #37 and #38, the
experimental IC50 value –SDothe additive IC50 valueothe experi-
mental IC50 valueþSD, so additive effects occur among the active
fractions of these three samples; For sample #35, its experimental
IC50 valueþSDo its additive IC50 value, so the active fractions of
sample #35 produces synergistic action.
Among the six samples in Fig. 2, the IC50 value of sample #33 is
the highest. It indicates that the cellular anti-inﬂammation of the
combination of the alkaloids of Strychnos nux-vomica and Ephedra
sinica (A) is inferior to that of the other ﬁve combinations.
However, when the ﬂavonoids of Glycyrrhiza uralensis (Fgu) were
added to sample #33, the IC50 value of the combination of A and
Fgu (sample #34) reduced more than one-half. It implies that the
addition of Fgu intensiﬁes the effect of #33 on PGE2 production
inhibition. Similarly, adding the saponins of Glycyrrhiza uralensis
and Cyathula ofﬁcinalis to #34 strengths its anti-inﬂammatory
activity because the IC50 of #35 is smaller than that of #34.
Moreover, the IC50 value of sample #35 is the lowest among the six
samples and only active fractions of this sample generates synergic
effect on PGE2 production inhibition. This may be why sample #35
is superior to sample #34 and the other four samples in cellular
anti-inﬂimmation. Glycyrrhiza uralensis is thought to have the
function of promoting the efﬁcacy of other herbs, and is commonly
used in many TCM formulae. The result of the present study
illustrates that the synergistic function of Glycyrrhiza uralensis is
mainly contributed by its saponins.
Since the experimental IC50 value of #37, #36 and #35 decrease
in turn, the anti-inﬂammatory activity of #35 is resisted when it is
combined with the volatile oil fractions (VbcþValþVesþVbb) of
YTNC, and the addition of the polysaccharides (PguþPcoþ
PalþPe) of YTNC to #36 decrease the anti-inﬂammatory activity
of #36. However, adding Chinese rice wine extract to #37
improves its anti-inﬂammatory activity because IC50 value of
#38 is greatly lower than #37. The result illustrates the reason-
ability of the YTNC's vehicle and its importance role on improving
the anti-inﬂammatory activity of YTNC.
In summary, sample #35 is the most effective combination
among the combinations of active fractions from YTNC. And the
YTNC whole recipe (#38) takes the second place, which demon-
strates the reasonability of the whole prescription of YTNC. The
combination of AeþAsþFguþSguþSco (sample #35) produces
good synergistic effect.
3.3. Effect of the combinations containing different kinds of
ﬂavonoids on inhibiting PGE2 production in ANA-1 cells
Fig. 3 compared the IC50 values on PGE2 production inhibition
of the combinations consisted of A (the alkaloids of Ephedra sinica
and Strychnos nux-vomica with equal ratio) and ﬂavonoids, which
changed with the CMM,. Sample #3 is the combination of A and
Fgu, which are the active fractions from YTNC. Compared with
sample #3, the IC50 value of sample #5 reduces signiﬁcantly.
Besides, the IC50 value of sample #5 is also lower than the other
three samples in the ﬁgure. The result indicates that the ﬂavonoids
of Carthamus tinctorius (Fct) produce higher anti-inﬂammatory
activity than the ﬂavonoids of Glycyrrhiza uralensis (Fgu) when the
ﬂavonoids combine with A. It is reported that Fct has a clear effect
on the treatment of inﬂammation by improving the level of nitric
oxide (Yin and Jin, 2004) and anti-platelet aggregation etc. (Jin et
al., 2004). Consequently, in light of the level of PGE2 production,
Fct are a perfectly acceptable substitute for Fgu, which was
extracted from the CMMs of YTNC.
In addition, the samples of #4 and #7 have higher IC50 values
than sample #3, indicating that the effect of the ﬂavonoids of
Epimedium sagittatum (Fes) in #4 and the ﬂavonoids of Taxillus
chinensis (Ftc) in #7 on inhibiting PGE2 production are not as good
as Fgu. As reported in the literatures (Chen et al., 2005a; Huang et
al., 2006; Xiao et al., 2009; see Table 1), the activity of Fes and Ftc
mainly focus on activating blood circulation and preventing bone
loss to achieve anti-inﬂammatory action. As for sample #6, there is
no signiﬁcant difference between the IC50 values of samples #6
and #3, indicating that the activity of the ﬂavonoids of Davallia
mariesii (Fdm) in #6 is similar to Fgu (#3).
In Fig. 4, the activities of the four samples #10–#13 containing
different saponins on inhibiting the secretion of PGE2 in ANA-1
cells were quantitatively compared. Among the four samples
demonstrated in this ﬁgure, sample #10 has the lowest IC50 value,
indicating that the saponins of Glycyrrhiza uralensis (Sgu) is most
effective in PGE2 production inhibition compared to the other
three saponins of Spn, Spg and Sco. The saponins of Sgu in #10 and
Sco in #13 are the active fractions from the CMMs of YTNC.
Compared to sample #10, the IC50 values of samples #11 and #12
increase signiﬁcantly, suggesting that the effect of the two samples
on PGE2 production inhibition greatly diminishes when the
saponins of Glycyrrhiza uralensis (Sgu) in #10 are replaced by the
saponins of Panax notoginseng (Spn) in #11 or the saponins of
Panax ginseng (Spg) in #12. Similarly, the activity of #11 is also
lower than that of #13. While there are no signiﬁcant difference
between the IC50 values of #12 and #13, illustrating that the PGE2
production inhibition activities of Spg and the saponins of
Cyathula ofﬁcinalis (Sco) are similar, which may result from their
same effects on strengthening immune activity (Sun et al., 2007;
Feng et al., 2012).
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The six samples of #17– #22 in Fig. 5 are only different in their
volatile oils/aqueous extracts, which are predominant in the
samples. The volatile oils/aqueous extracts in samples #17, #18,
#21 and #22 are the active fractions from the CMMs of YTNC.
Fig. 5 shows that the IC50 values of samples #19 and #20 are
signiﬁcantly lower than that of samples #17, #18, #21 and #22,
suggesting that the volatile oils of Angelica pubescens (Vap in #19)
and the volatile oils of Cinnamomum cassia (Vcc in #20) are better
than those from YTNC on inhibiting PGE2 production. Actually, it
has been reported that Vap and Vcc exert an effect on treating
inﬂammation and microbial infections (Xu et al., 2007; Fan et al.,
2009). The results provide the evidence of the pharmacological
effect of Vap and Vcc at cellular level. Since some adverse reactions
have been reported that the TCMs containing Boswellia sacra and
Commiphora myrrha may lead to liver damage (Hou, 2003; Li et al.,
2008), and Fig. 5 indicates that the anti-inﬂammatory activity of
volatile oils/aqueous extracts from YTNC are inferior to that of Vap
and Vcc, using Vap and Vcc to substitute the volatile oils/aqueous
extracts in YTNC would improve the safety and anti-inﬂammatory
effect of YTNC.
In Fig. 6, the six samples of #27–#32 are combined with AFSV
(i.e., the mixture of alkaloids, ﬂavonoinds, saponins and volatile
oils/aqueous extracts in equal ratio) and six different polysacchar-
ides, respectively, which are predominant in the six samples. The
effects of the six polysaccharides of Pco, Pgu, Pe, Pes, Pal and Ptc
on PGE2 production inhibition were evaluated by comparing the
Table 3
Cell Viability of the TCM Samples on ANA-1 Cells.
Final concentration (μg/mL) Sample Number
#3 #4 #5 #6 #7 #10
400.0 3.51170.061 2.86070.035nn 3.42770.032n 3.30770.019nn 0.29070.007nn 2.40670.030nn
200.0 3.34270.091 3.25170.046 3.33970.115 3.18070.059 2.93870.060nn 3.25270.053
100.0 3.25470.040 3.32770.105 3.32770.078 3.11670.073n 3.07270.065n 3.22270.055
50.0 2.98670.177n 3.11970.080nn 3.22070.081nn 2.82070.017 2.73170.127 2.67770.286
25.0 2.81870.092 3.21670.167nn 3.22870.177nn 2.55570.193nn 2.62770.161n 2.42070.179nn
12.5 3.05170.053 3.12270.077 3.20970.122 2.96170.044 2.98370.062 2.92770.042
6.2 3.14870.154 3.33270.091 3.24970.059 3.17070.067 3.19470.026 3.05470.050
3.1 3.29170.043 3.28270.018 3.29170.052 3.17970.046 3.24170.047 3.18570.011
Final concentration (μg/mL) #11 #12 #13 #17 #18 #19
400.0 3.47270.019 3.46470.015 3.42170.155n 3.48670.064 3.48970.026 3.53370.234
200.0 3.21970.042 3.36970.046 3.26570.081 3.35370.087 3.26770.063 3.30770.071
100.0 3.11970.026 3.39470.079 3.26970.037 3.27170.147 2.95270.288n 3.25270.070
50.0 2.43970.412n 3.22270.098nn 3.17370.080nn 3.11570.124nn 2.62270.377 2.77070.253
25.0 2.27070.182nn 3.29370.190nn 3.09970.056nn 3.16070.113nn 2.64870.338 2.61770.367
12.5 2.95170.085 3.22870.127 3.09270.133 3.02370.229 2.81570.076n 2.90770.074
6.2 3.04170.045 3.31270.094 3.20070.101 3.18370.156 2.98670.101 2.99270.023
3.1 3.24870.087 3.29170.049 3.29770.035 3.29870.100 3.13070.011 3.18670.022
Final concentration (μg/mL) #20 #21 #22 #27 #28 #29
400.0 0.12870.005nn 3.52670.174 3.44870.047 0.10270.002nn 3.32570.159nn 0.09970.003nn
200.0 0.09570.006nn 3.31770.172 3.17270.070 3.27370.021 3.38470.089 0.05070.004nn
100.0 0.08770.002nn 3.21370.107 2.93270.075nn 3.22870.060 3.38770.067 3.25970.189
50.0 2.68670.203 3.06670.254n 2.53270.090 2.87270.288 3.27070.066nn 3.23870.166nn
25.0 3.33670.104nn 3.06870.169 2.69970.127 3.01870.100 3.31270.062nn 3.21470.104nn
12.5 3.20670.119 3.05370.089 2.82870.101n 3.07170.067 3.18970.135 3.07370.207
6.2 3.27670.077 3.34070.040 2.95170.518 3.06170.039 3.32770.080 3.18070.075
3.1 3.27370.029 3.20670.102 3.20270.088 3.23770.01 3.34370.051 3.25970.085
Final concentration (μg/mL) #30 #31 #32 #33 #34 #35
200.0 0.08870.008nn 3.61470.039 0.10670.002nn 3.57770.022 3.35770.078n 3.59770.154
100.0 3.20270.039 3.29770.021 3.37470.095 3.42170.095 3.05670.032n 3.44270.046
50.0 3.06570.200n 3.11470.068 3.50070.087n 3.27470.121 2.77270.088nn 3.07670.162n
25.0 2.78670.157 2.68470.256 3.27870.143nn 3.11070.199nn 2.41270.339nn 2.63070.229
12.5 2.85570.066 2.68970.166 3.26970.076nn 3.09370.230n 2.43270.153nn 2.69570.22
6.2 2.83970.213n 3.02870.021 3.22170.078 3.07370.177 2.74570.037nn 2.86470.066n
3.1 3.02170.088 3.12270.023 3.32470.039 3.23270.101 3.01270.065 3.06970.026
400.0 3.19370.037 3.29870.037 3.32770.062 3.19870.051 3.13070.087 3.16770.015
Final concentration (μg/mL) #36 #37 #38 blank group
400.0 3.59070.036 3.50870.069 3.53070.073 3.63170.142
200.0 3.36270.052 3.42970.057 3.29270.055 3.32570.057
100.0 3.38670.130 3.38270.115 3.10270.135 3.30370.063
50.0 3.11970.170nn 3.25970.099nn 2.81970.179 2.76370.188
25.0 3.18870.179nn 3.13670.119nn 2.86970.141 2.85370.239
12.5 3.05770.148 3.14570.113 2.91770.184 3.10870.012
6.2 3.29870.076 3.22570.109 3.03670.054 3.18970.029
3.1 3.26770.057 3.26170.059 3.22770.014 3.33170.029
nn Indicates signiﬁcant differences as compared to blank group (po0.01).
n Indicates differences as compared to blank group (po0.05).
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IC50 values of the samples. The polysaccharides of Pco, Pgu, Pal and
Pe in samples #27, #28, #29 and #30 are the active fractions from
the CMMs of YTNC. Compared to samples #27-#30, the IC50 value
of sample #31 ascends signiﬁcantly, implying that the effect of Pes
on inhibiting the production of PGE2 is considerably unfavorable to
the polysaccharides of Pco, Pgu, Pal and Pe. However, there are no
signiﬁcant differences between the IC50 values of samples #32 and
#27– #30. This result indicates that the polysaccharides of Taxillus
chinensis have a similar activity of inhibiting PGE2 production as
the polysaccharides from the CMMs of YTNC.
3.4. Comparisons of the all TCM samples on PGE2 production
inhibition
We screened out some samples with good anti-inﬂammatory
activity from the 27 TCM samples according to the results of
Fig. 3–6 and listed their experimental IC50 values with SD. The ﬁrst
two rows of Table 4 indicate that there is no signiﬁcant difference
between the IC50 values of #35 and #38. In consideration of fewer
active fractions and CMMs in sample #35, it is much easier to
control the quality of #35 than #38.
Since sample #20 has the lowest IC50 value and sample #38 is
the whole formula of YTNC, we compared the signiﬁcant differ-
ence between the IC50 values of other samples and the two
samples in Table 4. The results indicate that in light of inhibiting
PGE2 production, those new designed TCM samples, which contain
some active fractions from the eight selected herbs, exert sig-
niﬁcantly higher activity than those from YTNC. It implies that the
YTNC formula could be improved from the point of cellular anti-
inﬂammation. Moreover, although sample #20 has the lowest IC50
Fig. 5. Effect of the combinations containing different volatile oils/aqueous extracts
on PGE2 production inhibition. Each experimental value represents IC50 value7SD.
aa indicates signiﬁcant differences as compared to #17 (po0.01), bb indicates
signiﬁcant differences as compared to #18 (po0.01), cc indicates signiﬁcant
differences as compared to #21 (po0.01), dd indicates signiﬁcant differences as
compared to #22 (po0.01).
Fig. 6. Effect of the combinations containing different polysaccharides on inhibit-
ing PGE2 production. Each experimental value represents IC50 value7SD. aa
indicates signiﬁcant differences as compared to #27 (po0.01), bb indicates
signiﬁcant differences as compared to #28 (po0.01), cc indicates signiﬁcant
differences as compared to #29 (po0.01), dd indicates signiﬁcant differences as
compared to #30 (po0.01).
Fig. 2. Experimental and additive IC50 values of six TCM samples derived from
YTNC. Each experimental value represents IC50 value7SD. Each additive value was
obtained by the method introduced in 2.5.
Fig. 3. Effect of the combinations of alkaloids and different ﬂavonoids on PGE2
production inhibition. Each experimental value represents IC50 value7SD.
n indicates differences as compared to #3 (po0.05), nn indicates signiﬁcant
differences as compared to #3 (po0.01).
Fig. 4. Effect of the combinations containing different saponins on PGE2 production
inhibition. Each experimental value represents IC50 value7SD. aa indicates
signiﬁcant differences as compared to #10 (po0.01). b indicates differences as
compared to #13 (po0.05).
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value among those investigated in this study, its IC50 value is not
signiﬁcantly lower than that of sample #5, #10 and #29. The fewer
active fraction and CMMs of #5 make it be superior to #20 in the
view of quality control and safety of TCM.
4. Conclusions
By means of investigating the activity of PGE2 production
inhibition of a series of well-designed YTNC-based TCM samples,
this work presents an innovative method to quantitatively evalu-
ate the effect of active fractions from the CMMs of TCM formulae
on the efﬁcacy, and synergistic/antagonistic/additive actions
among these active fractions. Furthermore, the reasonability,
advantage or disadvantage of the YTNC formula was validated
based on the assessment results. It is shown that both the
disassembled formulae and the whole formula of YTNC have the
activity of PGE2 production inhibition, and there are no signiﬁcant
differences between the activities of these samples derived from
YTNC. The addition of the extract of the vehicle of YTNC-Chinese
rice wine enhances the anti-inﬂammatory activity of YTNC.
It indicates the important role and the reasonability of the vehicle
of TCM. From the point of anti-inﬂammatory activity, the YTNC
formula could be improved by reducing its CMMs' categorizes or
using some other active fractions from the eight selected herbs to
replace some active fractions in YTNC. Speciﬁcally, using the
ﬂavonoids of Carthamus tinctorius, the volatile oils of Cinnamomum
cassia (or Angelica pubescens) to replace the ﬂavonoids and the
volatile oils/aqueous extracts of YTNC, respectively, will improve
the safety and anti-inﬂammation activity of YTNC. Certainly,
further evaluation of other activities of the 27 TCM samples should
be done to test the possibility of reducing the components
involved in YTNC formula, and developing more effective and
safer TCM using YTNC as prototypes. Limited by the length of this
article, the evaluation of the effects of the 27 TCM samples on
strengthening immunity, alleviating pain and promoting blood
circulation etc. will be introduced in our other reports.
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